Patent Assignment
Reel/Frame 073256/0932
Assignment of Assignor's Interest
Recorded: 2025-12-18
Pages: 15
Assignor
OMGA LIQUIDATING, INC. (F/K/A OMEGA THERAPEUTICS, INC.)
Executed: 2025-04-25
Assignee
FLAGSHIP LABS 114, INC. (F/K/A PIONEERING MEDICINES 08-B, INC.)
55 CAMBRIDGE PARKWAY, SUITE 800E, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property
(1)
Methods and Compositions for Modulating CTNNB1 Expression
PCT:
PCT/US2024/038677 ↗
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 23, 2024
From: MORRISON-SMITH, CHEVAUN DANIELLE; FARELLI, JEREMIAH D.; CHEN, JUSTIN; O'DONNELL, CHARLES W.
To: OMEGA THERAPEUTICS, INC.
Reel/Frame 068663/0669 →
Security Interest
Feb 10, 2025
From: OMEGA THERAPEUTICS, INC.
To: PIONEERING MEDICINES 08- B, INC.
Reel/Frame 070167/0243 →
Change of Name
Feb 5, 2026
From: FLAGSHIP LABS 114, INC.
To: SEPIA THERAPEUTICS, INC.
Reel/Frame 074719/0247 →